Сообщения

Сообщения за Декабрь, 2016

Nvidia leads S&P's winners in 2016; drug companies slump

Nvidia leads S&P's winners in 2016; drug companies slump
Chipmaker Nv... . FILE - In this March 4, 2015, file photo, Viji Arumugam, a scientist at Vertex Pharmaceuticals Inc., works on a test in her laboratory in San Diego.

from Biotech News

Microsoft Edge: Gespeicherte Passwörter anzeigen und bearbeiten

Изображение
Microsoft Edge: Gespeicherte Passwörter anzeigen und bearbeiten
Zugangsdaten von Webseiten speichern ist bei den meisten Browsern kein Problem mehr. Sie erkennen die Eingabe von Zugangsdaten automatisch und bieten dann die Speicherfunktion an. Allerdings ist die Anzeige und das Bearbeiten von Login-Daten -aus gutem Grund – ziemlich versteckt und erfordert etliche Mausklicks. So auch beim Edge-Browser von Microsoft.Das Bearbeiten von gespeicherten Passwörtern kann direkt im Passwort-Manager des Browsers erledigt werden. Die Anzeige in Klarschrift ist allerdings nur über die Systemsteuerung möglich. Aber alles der Reihe nach.Kennwörter bearbeitenÖffne den Passwort-Manager, indem du zuerst auf das Drei-Punkte-Menü-Icon im Edge-Browser klickst und anschließend auf Einstellungen | Erweiterte Einstellungen anzeigen. Dann scrollst du zum Bereich Datenschutz und Dienste.In diesem Bereich wird die Speicherung der Zugangsdaten von Webseiten über den Schalter gesteuert. Der Link Meine gespeichert…

Connect Group PLC (CNCT) Given Average Rating of "Buy" by Analysts

Connect Group PLC (CNCT) Given Average Rating of "Buy" by Analysts
Connect Group PLC has been assigned an average recommendation of "Buy" from the six ratings firms that are presently covering the firm. Six investment analysts have rated the stock with a buy rating.

from Biotech News

Endo International Is Top 'Dog of the S&P 500'

Endo International Is Top 'Dog of the S&P 500'
Never mind Dogs of the Dow , how about Dogs of the S&P 500 ? There are a lot more of them -- for instance, Endo International . Year to date, shares of specialty pharmaceutical company Endo looks to end 2016 down over 74%, the worst performing stock in the S&P 500.

from Biotech News

Icon Plc Forecasted to Post Q3 2017 Earnings of $1.28 Per Share

Icon Plc Forecasted to Post Q3 2017 Earnings of $1.28 Per Share
First Analysis issued their Q3 2017 earnings per share estimates for Icon Plc in a note issued to investors on Thursday. First Analysis analyst T. Van.

from Biotech News

Hospitals Warn Patients of Infection Tied to Medical Device

Hospitals Warn Patients of Infection Tied to Medical Device
Thousands of open-heart surgery patients may be at risk for a dangerous infection linked to a medical device used at hospitals across the country, including many in the Chicago area. Katie Kim reports.

from Biotech News

Forget Procter & Gamble Co.: These 2 Stocks are Better Buys

Forget Procter & Gamble Co.: These 2 Stocks are Better Buys
The consumer products industry is bracing for another year of sluggish global growth and brutal competition. Those dynamics mean that Procter & Gamble , despite its improved portfolio and lower cost structure, might again post disappointing operating results.

from Biotech News

Press release distribution, EDGAR filing, XBRL, regulatory filings

Press release distribution, EDGAR filing, XBRL, regulatory filings
PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH IN... )--Sequans Communications S.A. , a leading provider of single-mode LTE wireless semiconductor solutions for Internet of Things and a wide range of broadband... )--Research and Markets has announced the addition of the "Stainless Steel Forgings Market Size And Forecast By Product, By Application, By Region And Trend Analysis From 2013... )--Research and Markets has announced the addition of the "Negative Pressure Wound Therapy Market By Product , Wound Type (Diabetic Foot Ulcers, Pres...

from Biotech News

Netflix: Filme auf Smartphones herunterladen

Netflix: Filme auf Smartphones herunterladen
Bei Netflix können jetzt auch auf mobilen Endgeräten Kinofilme heruntergeladen und offline angesehen werden.Das Unternehmen bestätigte kürzlich, dass die Downloads mit der neuesten Version der Netflix-App sehr gut funktionieren. Die Geräte müssen mindestens mit den Betriebssystemen Android 4.4.2 und iOS 8.0 ausgestattet sein und es sollte für den Download eine stabile WLAN-Verbindung zur Verfügung stehen.Das Herunterladen von Videos ist genauso einfach wie das Streamen. Einfach den Film auswählen, auf den Download-Link klicken und die Videoqualität festlegen. Das war es dann schon.Über die Menü-Schaltfläche und der Kategorie Meine Downloads kannst du die gespeicherten Movies und Serien verwalten. Zum Löschen tippst du zuerst auf den entsprechenden Eintrag und dann auf das Löschsymbol. Eine Löschung aller Filme auf einen Schlag ist ebenfalls möglich.

Supported by World News Digest

Nvidia leads S&Pa s winners in 2016; drug companies slump

Nvidia leads S&Pa s winners in 2016; drug companies slump
In a solid year for stocks, graphics processor maker Nvidia stood far above its peers on the Standard & Poor's 500 index. The company's stock more than tripled for the year.

from Biotech News

CDC Considers Lowering Threshold Level for Lead Exposure

CDC Considers Lowering Threshold Level for Lead Exposure
The U.S. Centers for Disease Control and Prevention is considering lowering its threshold for elevated childhood blood lead levels by 30 percent, a shift that could help health practitioners identify more children afflicted by the heavy metal. Since 2012, the CDC, which sets public health standards for exposure to lead, has used a blood lead threshold of 5 micrograms per deciliter for children under age 6. While no level of lead exposure is safe for children, those who test at or above that level warrant a public health response, the agency says.

from Biotech News

Indiana receives nearly $300K in grants to fight Zika virus

Indiana receives nearly $300K in grants to fight Zika virus
The News and Tribune reports the Centers for Disease Control and Prevention has announced $184 million in grants for communities across the U.S. Indiana will get $200,000 for information gathering and rapid detection of microcephaly. The brain defect may occur when a mother is infected with Zika while pregnant.

from Biotech News

Swiss stocks - Factors to watch on Friday

Swiss stocks - Factors to watch on Friday
Johnson & Johnson is negotiating a deal to acquire the Swiss biotechnology company that would separate its commercialized portfolio from its research and development assets, people familiar with the matter told Reuters on Thursday. ANKARA, Dec 30 The Turkish parliament's constitutional commission approved a draft constitutional reform law on Friday, paving the way for the general assembly to debate a bill expanding the president's powers, parliamentary sources said.

from Biotech News

Deals of the day-Mergers and acquisitions

Deals of the day-Mergers and acquisitions
** Greece's largest lender Piraeus Bank said that it had completed the sale of a majority stake in its Cyprus subsidiary to Holding M. Sehnaoui SAL for 3.2 million euros , reducing its stake to 17.7 percent. ** Brazilian travel agency CVC Brasil Operadora e Agencia de Viagens SA will buy smaller rival Experimento for 41 million reais , the company said in a securities filing.

from Biotech News

Amgen Is Top Safe Nasdaq Dog For Year-End Gains

Amgen Is Top Safe Nasdaq Dog For Year-End Gains
The December survey showed 90% of the 51 NASDAQ index members showed safe margins of cash flow to sustain their payouts as of 12/27/16. 46 of 51 NASDAQ index dogs paid dividends regarded as safe because their free cash flow yield exceeded dividend yield.

from Biotech News

Emergent BioSolutions to Participate in First Quarter 2017 Investor Conferences

Emergent BioSolutions to Participate in First Quarter 2017 Investor Conferences
Emergent BioSolutions Inc. announced today that a member of the company's senior management team will participate in the following investor conferences during the first quarter of 2017. Presentation dates and times will be updated on the Emergent website http://ift.tt/1hL9r1a under "Investors" as this information becomes available.

from Biotech News

Finanzen: Konsumkredit : Verbraucherkredit im Handel

Konsum macht Spaß – am besten ohne Kredit. Wer für wichtige Anschaffungen dennoch einen Verbraucherkredit aufnehmen muss, sollte einige Varianten kennen.

from Finanztip Feed
Supported by Video Collection

Obama's Gift To The Biotech Industry

Obama's Gift To The Biotech Industry
If a drug has already been approved by the FDA, firms can rely on real world evidence to seek approval for additional indications. Clinical trials are incredibly expensive and the ability to rely on data collected outside traditional drug trials presents an incredible cost savings opportunity.

from Biotech News

Microsoft: Neue Hilfeseite zur Fehlerbehebung ist online

Microsoft: Neue Hilfeseite zur Fehlerbehebung ist online
Microsoft und seine kryptischen Fehlermeldungen sind ein running Gag seit es die Windows-Betriebssysteme gibt. Myriaden von hilfesuchenden Nutzern durchstöbern täglich das Netz nach Hilfe. Diese bietet jetzt auch eine offizielle Webseite von Microsoft an.Das Tool Fix Windows Update Errors ist die kürzlich veröffentlichte Hilfeseite, die eine Lösung für einige der Fehlercodes bereit halten soll.Im Einzelnen werden folgende Codes behandelt: 0x80073712, 0x800705B4, 0x80004005, 0x80070020, 0x80070422, 0x8024200B, 0x80070003, 0x80070643,0x80070002, 0x8024402FMicrosoft verspricht auf der Webseite aber auch, dass die Hilfe auch bei anderen Fehlercodes funktionieren soll.Wer anstatt der englischsprachigen Hilfeseite lieber die deutsche Variante bevorzugt, klickt hier, oder ändert in der Adresszeile die Spracheinstellung en-gb auf de-de.Bei Computern mit Windows 8 funktioniert Fix Windows Update Errors nicht und sollte daher auf die Versi…

Johnson & Johnson's 4 Biggest Catalysts in 2017

Johnson & Johnson's 4 Biggest Catalysts in 2017
Though it was a very difficult year for drugmakers, with the SPDR S&P Pharmaceuticals ETF losing just shy of a quarter of its value, the same can't be said of healthcare conglomerate Johnson & Johnson , a company that leans heavily on its pharmaceutical segment for its growth and gross margin. Through Dec. 28, J&J is up a healthy 12% year to date.

from Biotech News

The Medicines Co. (MDCO) Given Average Rating of "Buy" by Analysts

The Medicines Co. (MDCO) Given Average Rating of "Buy" by Analysts
Shares of The Medicines Co. have received a consensus rating of "Buy" from the thirteen brokerages that are covering the stock.

from Biotech News

Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Agrees To Settle With The SEC Over Corruption Charges

Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Agrees To Settle With The SEC Over Corruption Charges
Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages. We only allow registered users to use ad blockers.

from Biotech News

Myriad Genetics to Present at the 2017 JP Morgan Healthcare Conference

Myriad Genetics to Present at the 2017 JP Morgan Healthcare Conference
Myriad Genetics, Inc. announced today that Mark C. Capone, president and CEO, Myriad Genetics, is scheduled to present at the 2017 JP Morgan Healthcare Conference at 6:00 p.m. ET on January 9, 2017, at the Westin St. Francis Hotel in San Francisco, California. The presentation will be available to interested parties through a live audio webcast accessible through a link in the investor information section of Myriad's website at www.myriad.com .

from Biotech News

Fortress Biotech Announces Publication on MB - 101 (IL13R 2 -...

Fortress Biotech Announces Publication on MB - 101 (IL13R 2 -...
Fortress Biotech Announces Publication on MB-101 for the Treatment of Glioblastoma in New England Journal of Medicine NEW YORK, Dec. 28, 2016 -- Fortress Biotech, Inc. , a biopharmaceutical company dedicated to acquiring, developing and commercializing novel pharmaceutical and biotechnology products, today announced that a patient case study from the Phase 1 clinical trial of MB-101 for the treatment of glioblastoma will be published in the December 29 edition of the New England Journal of Medicine. MB-101 is the lead development candidate of Mustang Bio, Inc., a Fortress Company.

from Biotech News

this story a-o

this story a-o
A team of Clemson University researchers and an Upstate businessman believe they can help make football a little safer by creating a facemask that can help reduce the severity of head injuries by increasing overall helmet protection. The researchers are Gregory Batt, an assistant professor in the Clemson food, nutrition and packaging sciences department; John DesJardins, an associate professor of bioengineering and director of the Laboratory of Orthopaedic Design and Engineering; and Alex Bina, a doctoral student in bioengineering who also is a graduate research assistant in food, nutrition and packaging sciences.

from Biotech News

Finanzen: Smart-Beta-ETFs : Smart-Beta-ETFs

Smart-Beta-ETFs versuchen, besser zu sein als der breite Markt. Sie filtern Aktien mit geringer Schwankung oder höher Dividenden aus einem breiteren Index heraus und bilden diese nach.

from Finanztip Feed
Supported by Video Collection

Study reveals promising results for airbag bike 'helmets'

Study reveals promising results for airbag bike 'helmets'
Mehmet Kurt and David Camarillo stand in the lab at the Stanford University Department of Bioengineering, where they conducted tests to study how effective inflatable bicycle helmets are in various types of impacts. Photo by Veronica Weber.

from Biotech News

Android: Backups von SMS-Nachrichten erstellen

Android: Backups von SMS-Nachrichten erstellen
In der Vergangenheit haben wir schon öfter über die Speicherung von WhatsApp-Chat-Verläufen bei Android-Geräten und iPhones berichtet. Aber auch SMS-Nachrichten, die trotz WhatsApp, Threems, Telegram & Co, immer noch zuhauf versendet werden, kann man sichern und an anderer Stelle speichern. Zum Beispiel bei Dropbox, Google Drive oder im eigenen E-Mail-Account.Alles was du zur Sicherung der SMS-Chats benötigst, ist die App SMS Backup & Restore von Carbonite. Sie ist kostenlos bei Google Play erhältlich.Die Bedienung ist einfach und intuitiv. Nach dem Start der App tippst du auf Sicherung und wählst die gewünschten Funktionen aus. Neben den Textnachrichten kannst du auch Anruflisten, Emojis und MMS-Nachrichten in die Datensicherung mit einbeziehen. Allerdings werden keine Multimediadateien (Bilder, Töne, Videos) gesichert.Dann wählst du deinen bevorzugten Hauptsicherungsort (Dropbox, lokale Sicherung, Google Drive) aus. Bei Bedarf ka…

Nvidia leads S&P's winners in 2016; drug companies slump

Nvidia leads S&P's winners in 2016; drug companies slump
This Oct. 10, 2013, file photo, shows an EpiPen epinephrine auto-injector, a Mylan product, in Hendersonville, Texas. Five of the 10 largest losses on the S&P 500 in 2016 went to drug companies.

from Biotech News

Achillion Announces Clinical Milestone for the Advancement of...

Achillion Announces Clinical Milestone for the Advancement of...
Achillion Pharmaceuticals, Inc. today announced that it has received a $15 million milestone payment from Janssen Research & Development, LLC., part of the Janssen Pharmaceutical Companies of Johnson & Johnson , related to enrollment in the OMEGA-1 Phase 2b global, clinical trial of JNJ-4178, a 3DAA combination of odalasvir, simeprevir, and AL-335 in patients with treatment-naive chronic hepatitis C virus infection without cirrhosis.

from Biotech News

Bioinformatics brings to light new combinations of drugs to fight breast cancer

Bioinformatics brings to light new combinations of drugs to fight breast cancer
Based on the study of cell signalling networks, the cell signals that drugs alter when they reach their target molecule, an exhaustive in silico analysis of the pairing of 64 therapeutic agents used to treat breast cancer has allowed researchers at the Institute for Research in Biomedicine to identify 10 new and previously untested combinations that hold potential for the treatment of breast cancer. Seven of the 10 combinations tested in breast tumour cells in vitro have shown a high level of synergy and one of these combinations has been validated in mice.

from Biotech News

Amgen: A Biotech Pioneer On Sale

Amgen: A Biotech Pioneer On Sale
Recent negative sentiment mostly driven by political bashing of price gouging pharmaceutical companies have driven the prices down for pharma and biotech companies in general. Amgen relies heavily on a small number of patent protected products which give pause to investors who are concerned about patent expirations and product obsolescence.

from Biotech News

Finanzen: Rückkehr in die GKV : Rückkehr in die GKV

Privat Krankenversicherte können nur in Ausnahmefällen in eine gesetzliche Kasse zurückkehren. Je nach Alter und Einkommen gibt es dafür unterschiedliche Wege.

from Finanztip Feed
Supported by Video Collection

Immunomedics Inc. (IMMU) Short Interest Update

Immunomedics Inc. (IMMU) Short Interest Update
Immunomedics Inc. saw a large growth in short interest in December. As of December 15th, there was short interest totalling 21,534,823 shares, a growth of 6.3% from the November 30th total of 20,267,701 shares.

from Biotech News

West Virginia settling drug suit against 2 more distributors

West Virginia settling drug suit against 2 more distributors
Two major prescription drug distributors have agreed to settle a West Virginia lawsuit alleging they fueled West Virginia's opioid epidemic with excessively large shipments of painkillers into the state over several years.

from Biotech News

BioCryst Pharmaceuticals Inc. (BCRX) Stock Rating Lowered by Zacks Investment Research

BioCryst Pharmaceuticals Inc. (BCRX) Stock Rating Lowered by Zacks Investment Research
According to Zacks, "BioCryst Pharmaceuticals, Inc. is a leader in the use of crystallography and structure-based drug design for the development of novel therapeutics to treat cancer, cardiovascular diseases, autoimmune diseases, and viral infections. The company is advancing multiple internal programs toward potential commercialization including Fodosine in oncology, BCX-4208 in transplantation and autoimmune diseases and peramivir in seasonal and life threatening influenza.

from Biotech News

Downloads ohne Umweg direkt in der Cloud speichern

Downloads ohne Umweg direkt in der Cloud speichern
Der häufigste Weg, Dateien in der Cloud zu speichern, führt bei den meisten PC-Nutzern über die eigene Festplatte. Im Normalfall ist das auch in Ordnung, da die Dateien zuerst auf dem Computer erzeugt oder bearbeitet wurden. Bei Downloads aus dem Internet sieht das schon etwas anders aus. Hier kann man sich zusätzliche Arbeitsschritte sparen. Dies gilt insbesondere für Dateien, die ohnehin für deinen Cloud-Speicher bestimmt sind.Chrome und Comodo DragonGoogle Drive macht uns das direkte Speichern besonders einfach. Bei Webbrowsern, die Chrome-Addons verwenden können, musst du zuvor die Erweiterung In Google Drive speichern herunterladen und installieren. Sie ist im Chrome Web Store kostenlos erhältlich. Die Nutzer des Chrome Browsers sowie des Comodo Dragon können das Addon direkt installieren und verwenden, Opera-User müssen dagegen einen kleinen Trick anwenden.Opera BrowserBevor Opera mit Chrome-Extensions arbeiten kann, ist ein weit…

Sanofi sues Novo Nordisk over diabetes drugs in the U.S.

Sanofi sues Novo Nordisk over diabetes drugs in the U.S.
Dec 27 France's Sanofi has filed a lawsuit in the United States accusing Novo Nordisk of falsely claiming that Sanofi insulin drugs would no longer be available for many U.S. patients so it could promote its competing drug. The complaint, filed by Sanofi US in U.S. District Court for the District of New Jersey on Dec. 23, seeks an order forcing Novo Nordisk to pay unspecified money damages and withdraw marketing materials for its drug Tresiba.

from Biotech News

Tom Price Appointment Bodes Well For Biotech In 2017

Tom Price Appointment Bodes Well For Biotech In 2017
Biotechnology stocks, particularly pharmaceutical stocks, are likely to do well in 2017 for several reasons. The likely appointment of Dr. Tom Price to serve in Donald Trump's cabinet as Secretary of Health and Human Services will be a major plus for 2017.

from Biotech News

Shareholder Alert: Class Action Lawsuit Against Alexion Announced by Holzer & Holzer

Shareholder Alert: Class Action Lawsuit Against Alexion Announced by Holzer & Holzer
The complaint alleges Alexion used unlawful sales practices with respect to Soliris during that time. According to the complaint, the Company's revenues attributable to Soliris sales were unsustainable as a result.

from Biotech News

Seattle Genetics' cancer drug put on clinical hold after four deaths

Seattle Genetics' cancer drug put on clinical hold after four deaths
Seattle Genetics Inc said four people had died in trials testing its experimental cancer drug, prompting the U.S. Food and Drug Administration to impose a clinical hold on several early-stage studies. Six patients with acute myeloid leukemia , a type of blood cancer, have been identified with liver toxicity and four have died, the company said on Tuesday.

from Biotech News

FDA approves Biogen drug for lead genetic cause of infant death

FDA approves Biogen drug for lead genetic cause of infant death
A pedestrian passes the sign outside the headquarters of Biogen Idec Inc. in Cambridge, Massachusetts June 18, 2008. The U.S. Food and Drug Administration on Friday said it has approved Biogen Inc's drug to treat spinal muscular atrophy, the leading genetic cause of death in infants.

from Biotech News

REFILE-FDA puts clinical hold on Seattle Genetics' cancer drug after 4 deaths

REFILE-FDA puts clinical hold on Seattle Genetics' cancer drug after 4 deaths
Dec 27 Seattle Genetics Inc said on Tuesday that four people had died in trials testing its experimental cancer drug, prompting the U.S. Food and Drug Administration to impose a clinical hold on several early-stage trials. The clinical holds have been initiated to evaluate the potential risk of liver toxicity in patients who were treated with the drug and underwent stem cell transplant surgery either before or after the treatment.

from Biotech News

Apricus Biosciences Announces the Launch of Vitaros for the Treatment ...

Apricus Biosciences Announces the Launch of Vitaros for the Treatment ...
Apricus Biosciences, Inc. , a biopharmaceutical company advancing innovative medicines in urology and rheumatology, today announced the launch of Vitaros A , Apricus' novel on-demand topical cream for the treatment of erectile dysfunction , in Lebanon by Elis Pharmaceuticals Ltd. . Richard Pascoe, Chief Executive Officer of Apricus, commented, "We are pleased to announce the first launch of Vitaros by Elis and look forward to their performance in the highly attractive Middle East ED market, which they estimate at approximately $200 million.

from Biotech News

Positive Clinical Utility Results of Crescendo's Vectra DA Test for...

Positive Clinical Utility Results of Crescendo's Vectra DA Test for...
SALT LAKE CITY, Dec. 27, 2016 -- Crescendo Bioscience, a wholly-owned subsidiary of Myriad Genetics, Inc. , today announced that new data on the use of VectraA DA test to predict treatment response in patients with rheumatoid arthritis published online in the journal Arthritis & Rheumatology .1 "This study highlights the clinical utility of the Vectra DA test to help predict treatment response to biologic and non-biologic therapies in methotrexate incomplete responders," said Elena Hitraya, M.D., Ph.D., chief medical officer, Crescendo Bioscience. "These results showed that Vectra DA performed better than clinical and single inflammatory biomarkers at predicting response to non-biological therapy intensification versus anti-TNF therapy.

from Biotech News

Press release distribution, EDGAR filing, XBRL, regulatory filings

Press release distribution, EDGAR filing, XBRL, regulatory filings
Cr... )--Gilead Sciences, Inc. today announced that its corporate presentation will be webcast from the 35th Annual J.P. Morgan Healthcare Conference in ... )--Technavio has published three reports, including analytical instrument market, freeze drying equipment Market, and global friction stir welding equipment, under the heavy i... )--Technavio has published three reports, including boric acid market, global polymethacrylate market in VII and PPD, and GF and GFRP composites market, under the chemicals an... )--Technavio has published three reports, including aeroderivative gas turbines, sheet metal equipment, and heat pumps, categorized under the tools and components sector.

from Biotech News

'Rogue One' pads Disney's record year

'Rogue One' pads Disney's record year
Rogue One kept its grip on North American movie fans over the Christmas weekend, giving the film a second straight win at the box office and pushing Disney further past its record $7B in annual global ticket sales.

from Biotech News

Swiss stocks - Factors to watch on Dec 26

Swiss stocks - Factors to watch on Dec 26
Dec 27 The Swiss blue-chip SMI was seen opening 0.1 percent higher at 8,241 points on Tuesday, according to premarket indications by bank Julius Baer . The SIX Swiss Exchange said U.S. hedge fund founder Dan Och, of Och-Ziff Capital Management Group, through a variety of investment vehicles holds more than 3.1 percent of shares in Swiss biotech Actelion that is being courted by possible buyers including Johnson & Johnson.

from Biotech News

Goldman Sachs Group Inc. Reiterates 126.00 Price Target for Bayer AG

Goldman Sachs Group Inc. Reiterates 126.00 Price Target for Bayer AG
The firm currently has a "buy" rating on the stock. Several other equities research analysts have also recently weighed in on BAYN.

from Biotech News

Alexion Pharmaceuticals Inc. (ALXN) PT Set at $211.00 by Leerink Swann

Alexion Pharmaceuticals Inc. (ALXN) PT Set at $211.00 by Leerink Swann
The firm presently has a "buy" rating on the biopharmaceutical company's stock. Leerink Swann's price objective points to a potential upside of 65.89% from the stock's current price.

from Biotech News

Analysts Anticipate RXi Pharmaceuticals Corp. (RXII) to Announce ($0.23) Earnings Per Share

Analysts Anticipate RXi Pharmaceuticals Corp. (RXII) to Announce ($0.23) Earnings Per Share
Shares of RXi Pharmaceuticals Corp. have received a consensus broker rating score of 1.00 from the two brokers that provide coverage for the company, Zacks Investment Research reports. Two equities research analysts have rated the stock with a strong buy recommendation.

from Biotech News

M&T Bank Corp Has $59,928,000 Position in Amgen Inc.

M&T Bank Corp Has $59,928,000 Position in Amgen Inc.
M&T Bank Corp decreased its position in Amgen Inc. by 0.2% during the third quarter, according to its most recent 13F filing with the SEC. The fund owned 359,264 shares of the medical research company's stock after selling 638 shares during the period.

from Biotech News

Alten Datenmüll im Ordner C:\Windows\Installer entfernen

Изображение
Alten Datenmüll im Ordner C:\Windows\Installer entfernen
Alte Datenreste von Festplatten entfernen ist immer eine gute Idee. Man muss nur wissen, was gefahrlos gelöscht werden kann. Das betrifft insbesondere den Ordner Installer. Hier werden Daten abgelegt, die für die Deinstallation von Programmen erforderlich sind. Bei der Löschung des Ordners oder falscher Dateien, kann es zu schwerwiegenden Problemen kommen. Da sich aber der Installer-Ordner mit der Zeit ziemlich aufbläht, benötigt man das richtige Werkzeug um nicht mehr benötigte Datenleichen zu entfernen.Das kostenlose Programm PatchCleaner von HomeDev prüft, welche Dateien im Verzeichnis C:\Windows\Installer nicht mehr benötigt werden und gefahrlos gelöscht werden können. Lade das Tool von der Webseite des Anbieters herunter und installiere es auf deinem PC.Bei der Installation des PatchCleaners kann es zu einer Malware-Warnung durch dein Antivirenprogramm kommen. Der Anbieter HomeDev versichert jedoch, dass das Programm keinerl…

Teva bribery settlement raises questions on Argentina, Romania probes

Teva bribery settlement raises questions on Argentina, Romania probes
A half-billion dollar settlement reached between Teva Pharmaceutical Industries Ltd. and the US government last week for the resolution of criminal charges in the bribery of officials in Russia, Ukraine and Mexico raises questions about the fate of other Teva bribery probes, in Argentina and Romania. Teva and the US Department of Justice said in separate statements on Thursday that they had reached a settlement over the charges relating to Russia, Ukraine and Mexico, and that Teva would pay a combined total of US criminal and regulatory penalties of almost $520 million.

from Biotech News

Teva Pharmaceutical Industries' (TEVA) Buy Rating Reiterated at Canaccord Genuity

Teva Pharmaceutical Industries' (TEVA) Buy Rating Reiterated at Canaccord Genuity
Several other research firms have also recently weighed in on TEVA. Guggenheim reiterated a "buy" rating and issued a $80.00 price target on shares of Teva Pharmaceutical Industries in a report on Tuesday, April 19th.

from Biotech News

Vertex Pharmaceuticals Inc. (VRTX) Raised to "Strong-Buy" at Vetr Inc.

Vertex Pharmaceuticals Inc. (VRTX) Raised to "Strong-Buy" at Vetr Inc.
The firm presently has a $94.50 price target on the pharmaceutical company's stock. Vetr 's target price would indicate a potential upside of 27.17% from the company's previous close.

from Biotech News

Credit Suisse Group AG Reiterates Underperform Rating for AstraZeneca plc

Credit Suisse Group AG Reiterates Underperform Rating for AstraZeneca plc
's stock had its "underperform" rating restated by equities researchers at Credit Suisse Group AG in a research note issued to investors on Monday. They presently have a GBX 4,000 target price on the biopharmaceutical company's stock.

from Biotech News

3 Big Pharma Stocks With the Fastest-Growing Dividends

3 Big Pharma Stocks With the Fastest-Growing Dividends
Hockey great Wayne Gretzsky famously said: "I skate to where the puck is going to be, not where it has been." I think the concept definitely applies to investing in dividend stocks.

from Biotech News

Capital Insight Partners LLC Lowers Stake in Johnson & Johnson

Capital Insight Partners LLC Lowers Stake in Johnson & Johnson
Capital Insight Partners LLC decreased its stake in Johnson & Johnson by 8.7% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 30,336 shares of the company's stock after selling 2,876 shares during the period.

from Biotech News

Alle Windows-10-Aktivitäten auf einen Schlag auflisten

Alle Windows-10-Aktivitäten auf einen Schlag auflisten
Manchmal möchte man wissen, wann ein Programm, ein Druckauftrag gestartet oder ein spezieller Ordner geöffnet wurde. Die Informationen der letzten Aktivitäten lassen sich über zwei Lösungswege abrufen.Alles einfacher mit NirsoftDie einfachste Variante ist das Tool LastActivityView von Nirsoft. Es ist über die Webseite des Anbieters kostenlos als ZIP-Datei erhältlich. Oder klicke hier, um das Tool direkt herunter zu laden. Nach dem Download entpackst du das Programm einfach nur in einem beliebigen Ordner. Eine Installation ist nicht erforderlich. Daher kann man es auch auf einem USB-Stick oder einer SD-Karte problemlos speichern.Wie bei allen anderen Nirsoft-Programmen auch, ist bei LastActivityView die Programmsprache Englisch. Weitere Sprachpakete (ZIP-Format) findest du auf der Webseite unterhalb des Download-Links. Lade das gewünschte Sprachpaket herunter und entpacke die lastactivityview_lng.ini in das Hauptverzeichnis von Last…

Biotech grows in the Berkshires

Biotech grows in the Berkshires
She points out various laboratory facilities that her company, Berkshire Sterile Manufacturing, has built in the former warehouse, which was originally used to store toys. These labs rest like islands in an ocean of open space, but Wagner sees these empty areas as a plus.

from Biotech News

Korean biopharmaceuticals to make inroad...

Korean biopharmaceuticals to make inroad...
A number of South Korean biopharmaceutical products will make their full-fledged debuts in the US next year, with the aim of taking a share of the world's largest market for pharmaceutical and health care goods. Leading the move is Celltrion, the developer of the world's first biosimilar drug referencing Johnson & Johnson's Remicade, which treats chronic inflammatory illnesses such as rheumatoid arthritis and Crohn's disease.

from Biotech News

Biotechnology: what it is and how it's about to change our lives

Biotechnology: what it is and how it's about to change our lives
Sang Yup Lee, distinguished professor at the Korea Advanced Institute of Science and Technology, and co-chair of the Global Future Council on Biotechnologies, explains how biotechnology is poised to change our lives and why it could one day be as commonplace as having a cell phone or a tablet. Biotechnology is a broad range of technologies that employs living organisms or parts of them to make diverse products.

from Biotech News

BioDelivery Sciences International Inc. (BDSI) Given Hold Rating at Cantor Fitzgerald

BioDelivery Sciences International Inc. (BDSI) Given Hold Rating at Cantor Fitzgerald
Several other equities analysts have also weighed in on BDSI. FBR & Co restated a "buy" rating on shares of BioDelivery Sciences International in a report on Saturday, March 12th.

from Biotech News

Big pharma won't stop raising prices -- it'll just do it smarter

Big pharma won't stop raising prices -- it'll just do it smarter
The president-elect tweeted he asked Boeing to draw up the price for an F/A-18 equivalent to Lockheed Martin's F-35. Amazon.com has reportedly brought in over 40 new cargo jets for a new service to meet delivery demand from the retail giant's customers.

from Biotech News

Not Just a Formality? USPTO Sequence Rules May Impact Existing Biotech Portfolios

Not Just a Formality? USPTO Sequence Rules May Impact Existing Biotech Portfolios
Patent applications containing nucleic acid or protein sequences are required to include an electronic sequence listing using a required format and standard symbols. The United States Patent and Trademark Office , in conjunction with the World Intellectual Property Organization , is participating in an international effort that, if implemented, would dramatically change the requirements for sequence listings for the first time in 18 years.

from Biotech News

Der „TrackR Bravo“ findet deine verlorenen Sachen schnell wieder

Изображение
Der „TrackR Bravo“ findet deine verlorenen Sachen schnell wieder
Viele Bastler und Tüftler haben sich dem Wiederfinden von verlorengegangenen Dingen verschrieben. Seit vielen Jahren gibt es sogenannte Schlüsselfinder, die auf einen Pfiff oder Händeklatschen mit einem Audiosignal reagieren. Der Nachteil dieser Schlüsselfinder ist zum Einen deren Größe und zum anderen die Zuverlässigkeit. Doch mit dem TrackR ist das kein Problem mehr.Bei den herkömmlichen Schlüsselfindern gibt es häufig Empfangsprobleme wenn Zeitungen oder Textilien die Empfangseinheit für das Pfeif- oder Klatschsignal verdecken. Zudem würde man in solchen Fällen auch das gesendete Audiosignal kaum hören.Im Gegensatz zu den streichholzschachtelgroßen Schlüsselfindern, hat der TrackR Bravo die Abmessungen einer Zwei-Euro-Münze, ist nur 3,5 mm dick und funktioniert mit Bluetooth 4.0. Das Audiosignal, das beim Suchvorgang ausgelöst wird, ist bis zu 85 Dezibel laut. Die austauschbare Knopfbatterie (CR1620) hält bis zu einem …

Rising Rates May Hurt Small-Cap Biotech ETF Valuations

Rising Rates May Hurt Small-Cap Biotech ETF Valuations
The Federal Reserve has hiked interest rates for the second time in a decade and plans to raise rates three more times next year. With higher interest rates, investors may find small-cap biotechnology exchange traded funds that track companies banking on a breakthrough drug less appealing.

from Biotech News

Better Buy: Celldex Therapeutics, Inc. vs. Exelixis

Better Buy: Celldex Therapeutics, Inc. vs. Exelixis
Two oncology-focused biotech stocks began 2016 with a dip but have diverged a great deal ever since. A successful label expansion made Exelixis, Inc. Should investors try to ride the Exelixis rocket even higher, or look for value in Celldex's burgeoning pipeline? Let's see how these two stack up to each other to find the better pick right now.

from Biotech News

Press release distribution, EDGAR filing, XBRL, regulatory filings

Press release distribution, EDGAR filing, XBRL, regulatory filings
The consumer book publishing market comprises ... )--Research and Markets has announced the addition of the "Asia - Mobile Infrastructure and Mobile Broadband" report to their offering. Asian mobile broadband market continues... )--Quercus Asset Selection, which specialises in renewable energy infrastructure investments, is pleased to announce that it has finalised the largest bond... )--Taro Pharmaceutical Industries Ltd. today announced the sale of U.S. rights to KeveyisA to Strongbridge Bi... )--Research and Markets has announced the addition of the "Record Production Global Market Briefing 2017" report to their offering.

from Biotech News

Glancy Prongay & Murray LLP Commences Investigation on Behalf of Sinovac Biotech Ltd. Investors

Glancy Prongay & Murray LLP Commences Investigation on Behalf of Sinovac Biotech Ltd. Investors
GPM is preparing a lawsuit on behalf of Sinovac investors. Sinovac is a biopharmaceutical company that engages in the research, development, manufacture and commercialization of vaccines against hepatitis A, hepatitis B, seasonal influenza, H5N1 and H1N1 pandemic influenza and mumps in the People's Republic of China.

from Biotech News

FDA OKs first treatment for rare genetic disorder

FDA OKs first treatment for rare genetic disorder
The Food and Drug Administration has approved the first treatment for children and adults with spinal muscular atrophy, a rare genetic disorder marked by progressive muscle weakness that's the most common genetic cause of death in infants.

from Biotech News

FDA approves Biogen drug for lead genetic cause of infant death

FDA approves Biogen drug for lead genetic cause of infant death
Dec 23 The U.S. Food and Drug Administration on Friday said it has approved Biogen Inc's drug to treat spinal muscular atrophy, the leading genetic cause of death in infants. The drug, nusinersen, which was discovered by Ionis Pharmaceuticals and licensed to Biogen, will be sold under the brand name Spinraza.

from Biotech News

Windows 10: Probleme mit der Internetverbindung nach Update beheben

Windows 10: Probleme mit der Internetverbindung nach Update beheben
Nicht immer läuft nach Microsoft-Updates alles besser. Manchmal kommen auch weitere Probleme hinzu. Dies betrifft auch etliche User, die seit dem letzten kumulativen Update (KB3201845) Schwierigkeiten mit der Internetverbindung bekommen haben. Die Lösung des Verbindungs-Problems führt über die Eingabeaufforderung.Am schnellsten öffnest du die Kommandozeile (mit Administratorrechten!) über das Suchfeld mit dem Begriff cmd. Alternativ öffnest du das Fenster Ausführen mit der Tastenkombination [Windows][R] und gibst auch hier den Befehl cmd ein.Im Fenster der Eingabeaufforderung tippst du zuerst den Befehl netsh winsock reset catalog ein und bestätigst ihn mit der Taste [Eingabe]. Anschließend wiederholst du diesen Arbeitsschritt mit dem Befehl netsh int ipv4 reset reset.log.Damit sollte die Internetverbindung wieder funktionieren. Wenn nicht, dann öffne die Kommandozeile mit Administratorrechten erneut. Gib den Befehl ip…

Neogen Corp. (NEOG) Posts Earnings Results, Beats Estimates By $0.02 EPS

Neogen Corp. (NEOG) Posts Earnings Results, Beats Estimates By $0.02 EPS
Neogen Corp. issued its earnings results on Wednesday. The company reported $0.29 earnings per share for the quarter, beating analysts' consensus estimates of $0.27 by $0.02.

from Biotech News

Cardinal Health in $10 million U.S. settlement over painkiller orders

Cardinal Health in $10 million U.S. settlement over painkiller orders
A drug distributor owned by Cardinal Health Inc has agreed to pay $10 million to resolve claims that it failed to alert the U.S. Drug Enforcement Administration to suspicious orders of addictive painkillers by New York-area pharmacies. The settlement with New York City-based pharmaceutical distributor Kinray LLC, disclosed in papers filed late on Thursday in Manhattan federal court, comes during efforts by U.S. authorities to combat the nation's opioid drug epidemic.

from Biotech News

Strongbridge Biopharma plc Announces Acquisition of U.S. Rights to KEVEYIS From Taro

Strongbridge Biopharma plc Announces Acquisition of U.S. Rights to KEVEYIS From Taro
Strongbridge Biopharma plc, , a global commercial-stage biopharmaceutical company focused on the development and commercialization of therapies for rare diseases with significant unmet needs, today announced that the Company has acquired the U.S. rights to KEVEYISA from a subsidiary of Taro Pharmaceutical Industries Ltd. . KEVEYIS was approved by the U.S. Food and Drug Administration in August 2015 to treat hyperkalemic, hypokalemic, and related variants of Primary Periodic Paralysis, which is a group of rare hereditary disorders that causes potentially severe episodes of muscle weakness and/or paralysis.

from Biotech News

White blood cell treatment could prevent leading cause of foetal death

White blood cell treatment could prevent leading cause of foetal death
Treating a type of white blood cell using hormones could improve the development of the placenta in women with pregnancy complications, according to early research led by Queen Mary University of London involving mice and human blood samples. Pre-eclampsia is a condition in some pregnant women that results in poor maternal blood vessel development in the placenta, leading to poor foetal growth.

from Biotech News

Final test results confirm Ebola vaccine highly effective

Final test results confirm Ebola vaccine highly effective
It's a major milestone in the search for a vaccine to stop future outbreaks, like the one that killed thousands in West Africa. Scientists have struggled to develop an Ebola vaccine over the years, and this is the first one proven to work.

from Biotech News

Most actively traded companies on the TSX

Most actively traded companies on the TSX
Bombardier Inc. . Aerospace, rail equipment. Up seven cents, or 3.37 per cent, to $2.15 on 7.3 million shares.

from Biotech News

Finanzen: Private Pflege-Zusatzversicherung : Ratgeber Pflege-Zusatzversicherung

Die gesetzliche Pflegeversicherung übernimmt nur einen Teil der Pflegekosten. Eine private Zusatzversicherung kann für die Absicherung sinnvoll sein.

from Finanztip Feed
Supported by Video Collection

Finanzen: Private Pflege-Pflichtversicherung : Private Pflege-Pflichtversicherung

Auch Privatpatienten sind verpflichtet, eine Pflegeversicherung abzuschließen. Das Einkommen spielt dabei keine Rolle.

from Finanztip Feed
Supported by Video Collection

United Rheumatology Issues Clinical Practice Guidelines and...

United Rheumatology Issues Clinical Practice Guidelines and...
Crescendo Bioscience, a wholly-owned subsidiary of Myriad Genetics, Inc. , today announced that United Rheumatology, a leading professional organization for rheumatologists in the United States with more that 300 members, has added Vectra A DA to its clinical practice guidelines for adults with rheumatoid arthritis . The guidelines are designed to assist United Rheumatology healthcare professionals in the diagnosis, treatment and monitoring of patients with RA to preserve function, optimize the achievement of remission or near remission, improve quality of life and monitor outcomes in the safest and most cost-effective fashion possible.

from Biotech News

J&J's Decision to Walk Away Set Stage for Renewed Actelion Talks

J&J's Decision to Walk Away Set Stage for Renewed Actelion Talks
Johnson & Johnson's willingness to walk away from talks to acquire Swiss biotechnology company Actelion Ltd. for about $28 billion is the very thing that got the two sides back to the negotiating table. This week, amid rising pressure from shareholders, Actelion surprised investors and re-entered negotiations with J&J, which signaled a willingness to raise its offer if granted exclusivity, said people familiar with the matter.

from Biotech News

WhatsApp, Frosch-Profilbilder und ein Rätsel

WhatsApp, Frosch-Profilbilder und ein Rätsel
Haben ein paar deiner WhatsApp-Kontakte plötzlich einen Frosch als Profilbild? Dann haben sie beim Frosch-Spiel versagt!Seit einiger Zeit kursiert unter WhatsApp-Nutzern ein Rätsel, dass bei falscher Beantwortung den Spieler als Strafe zum Ändern des Profilbildes auffordert. Ein passendes Frosch-Bild wird meist direkt mitgeliefert. Für die nächsten 24 Stunden bist du dann als Frosch gebrandmarkt.Der Rätsel-Text lautet wie folgt:Du schläfst seelenruhig in deinem Bett. Um sieben Uhr morgens hörst du auf einmal die Klingel, unangekündigter Besuch! Deine Freunde kommen spontan zum Frühstücken vorbei. Du hast Marmelade, Honig, Nutella und Käse im Kühlschrank. Was machst du zuerst auf?Du machst als erstes natürlich nichts aus dem Kühl- oder Küchenschrank auf. Da der Wecker gerade geschellt hat, ist das Erste was du aufmachst, logischer Weise deine Augen!Mit dieser Antwort kannst du dein bisheriges Profilbild beibehalten.Das Frosch-Rätsel gibt es a…

Teva to pay US government $519 mln over foreign bribery charges

Teva to pay US government $519 mln over foreign bribery charges
Dec 22 Israel's Teva Pharmaceutical Industries Ltd , said on Thursday it had agreed to pay $519 million to resolve charges related to the U.S. Foreign Corrupt Practices Act. The settlement with the Department of Justice and the Securities and Exchange Commission relates to conduct in Ukraine, Mexico and a guilty plea by a subsidiary in Russia, and followed a voluntary investigation, Teva said.

from Biotech News

Teva to pay US government US$519 million over foreign bribery charges

Teva to pay US government US$519 million over foreign bribery charges
Israel's Teva Pharmaceutical Industries Ltd , said on Thursday it had agreed to pay US$519 million to resolve charges related to the U.S. Foreign Corrupt Practices Act. REUTERS: Israel's Teva Pharmaceutical Industries Ltd , said on Thursday it had agreed to pay US$519 million to resolve charges related to the U.S. Foreign Corrupt Practices Act.

from Biotech News

SEC, DOJ fine Teva Pharmaceutical $519 million to settle foreign bribery charges

SEC, DOJ fine Teva Pharmaceutical $519 million to settle foreign bribery charges
Teva made more than $214 million in illicit profits, according to the SEC, by bribing officials to increase its market share, obtain regulatory approvals and gain favorable drug purchase and prescription decisions. Teva will enter into a deferred prosecution agreement with the U.S. Department of Justice.

from Biotech News

Stocks sink further as retailers lead US indexes lower

Stocks sink further as retailers lead US indexes lower
U.S. stocks are lower Thursday as retailers slide. Bed Bath & Beyond is down after posting weak sales, while e-commerce company Alibaba is down after regulators again sanctioned the company for sales of counterfeit goods.

from Biotech News

European shares dip but Italy outperforms despite Monte Paschi volatility

European shares dip but Italy outperforms despite Monte Paschi volatility
LONDON, Dec 22 European shares edged lower on Thursday, dropping further from their highest levels of the year, though Italian blue-chips outperformed as they shrugged off uncertainty over Monte Paschi's rescue plan. Drugmaker Actelion provided support as it surged to a new record high after it entered exclusive discussions with prospective bidder Johnson & Johnson.

from Biotech News

FDA accepts Pfizer's marketing application for expanded use of breast ...

FDA accepts Pfizer's marketing application for expanded use of breast ...
The FDA accepts for review Pfizer's supplemental New Drug Application seeking approval for the use of IBRANCE , in combination with letrozole, to treat postmenopausal women with estrogen receptor-positive, human epidermal growth factor receptor 2-negative metastatic breast cancer. The application includes data from the Phase 3 PALOMA-2 study which was conducted in the same patient population as the Phase 2 PALOMA-1 trial, the basis for accelerated approval status granted by the FDA in February 2015.

from Biotech News

Heartburn for Defense After Jury Verdict in Pepcid Dispute

Heartburn for Defense After Jury Verdict in Pepcid Dispute
The recent jury verdict in a dispute over a generic version of the heartburn medication Pepcid Complete would be enough for anyone to reach for a few tablets of the accused product. After an eight day trial presided over by Judge Zobel, a Massachusetts jury last week returned a verdict for Plaintiffs Brigham and Women's Hospital and Investors Bio-Tech, L.P. .

from Biotech News

Finanzen: Erbrecht : Erbrecht

Früher oder später betrifft das Thema Erbrecht jeden – etwa wenn ein naher Angehöriger stirbt oder wenn Sie Ihre Lieben finanziell absichern wollen, falls Ihnen etwas zustößt.

from Finanztip Feed
Supported by Video Collection

Finanzen: Gesetzliche Pflegeversicherung : Gesetzliche Pflegeversicherung

Die Mitgliedschaft in der Pflegeversicherung ist gesetzlich vorgeschrieben. Im Pflegefall übernimmt die Pflichtversicherung jedoch nicht alle Kosten.

from Finanztip Feed
Supported by Video Collection

Bad News Bashes Biotech Investors... Again

Bad News Bashes Biotech Investors... Again
Alexion's top brass has hit the exits amid an investigation into sales practices, and Ophthotech's future is in jeopardy following a high-profile phase 3 failure. At Alexion Pharmaceuticals, the sudden departure of top executives in the midst of an ongoing internal investigation caused its shares to tumble 13%.

from Biotech News

Actelion verhandelt nun mit Johnson & Johnson exklusiv

Actelion verhandelt nun mit Johnson & Johnson exklusiv
(dpa-AFX) Eine Woche nachdem Johnson & Johnson (J&J) seine Übernahmegespräche mit Actelion als beendet erklärt hatte, meldet Actelion am Mittwochabend neue Gespräche mit dem US-Konzern. Diesmal seien es "exklusive Verhandlungen" um eine "mögliche strategische Transaktion". Es gebe keinerlei Gewähr, ...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.

Wall Street slips, stocks ease from records

Wall Street slips, stocks ease from records
In 12.56pm trading in New York, the Dow Jones Industrial Average slipped 0.06 per cent, while the Nasdaq Composite Index moved 0.15 per cent lower. In 12.41pm trading, the Standard & Poor's 500 Index eased 0.08 per cent.

from Biotech News

Finanzen: Pflegeversicherung der Rentner : Pflegeversicherung der Rentner

Auch Senioren zahlen in die Pflegekasse ein. Anders als bei der Krankenversicherung müssen Rentner ihre Beiträge in voller Höhe selbst tragen.

from Finanztip Feed
Supported by Video Collection

Appeals court sides with Utah in blow to contact lens makers

Appeals court sides with Utah in blow to contact lens makers
A federal appeals court is dealing a blow to contact lens makers who tried to set minimum charges for their products amid bitter price wars in the $4 billion industry. At least one major manufacturer, Johnson & Johnson, has already moved away from the pricing programs that were designed to protect eye doctors from being undercut by retailers like Utah-based 1-800 Contacts.

from Biotech News

Schärfemolekül bremst Wachstum von Brustkrebszellen

Изображение
Schärfemolekül bremst Wachstum von Brustkrebszellen

Der Geschmacksstoff Capsaicin macht Peperoni scharf. Ein feuriges Geschmackserlebnis ist aber längst nicht die einzige Wirkung, die er auf den Körper haben kann. Capsaicin, ein Inhaltsstoff von scharfen Substanzen wie Peperoni oder Pfeffer, hemmt das Wachstum von Brustkrebszellen. Die RUB-Forscher P...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.

WhatsApp: Versteckte Schriftarten-Funktion im Chat verwenden

WhatsApp: Versteckte Schriftarten-Funktion im Chat verwenden
Einzelne Begriffe oder kurze Textpassagen in einem Text hervorzuheben ist mit Textverarbeitungsprogrammen auf dem PC nicht besonders schwer. Etliche Features stehen dem Nutzer dafür zur Auswahl. Etwas anders sieht das bei Messengern wie WhatsApp aus. Wollte man in der Vergangenheit etwas besonders hervorheben, musste man es in Großbuchstaben schreiben oder Anführungszeichen verwenden. Dafür gibt es bei WhatsApp nun eine andere Lösung.Seit einiger Zeit gibt es vier versteckte Chat-Codes, mit denen Nachrichten-Texte fett, kursiv und durchgestrichen dargestellt werden können. sogar ein neue Schriftart kannst du verwenden.Die benötigten Zeichen werden jeweils vor und hinter dem zu formatierenden Text eingegeben.Kursive Texte werden mit dem Unterstrich erzeugt: _kursiv_Fettschrift mit der [*]-Taste: *fett*und durchgestrichener Text mit dem Tilden-Zeichen [~]: ~durchgestrichen~Um die vierte Funktion, die WhatsApp Schriftart FixedSy…

Sinovac Biotech: Court Documents Show CEO Bribed Chinese FDA, Buyout Offers Could Be In Jeopardy

Sinovac Biotech: Court Documents Show CEO Bribed Chinese FDA, Buyout Offers Could Be In Jeopardy
Recently disclosed court documents show that Sinovac Biotech's CEO bribed a member of the Chinese Food and Drug Administration to assist its vaccine clinical trial and approval. Bribery is a clear violation of Foreign Corrupt Practices Act regulations and is prohibited for SEC registered companies like SVA; it could lead to criminal prosecution and fines.

from Biotech News

RPT-Investors see Biogen CEO choice as friendly to potential takeover

RPT-Investors see Biogen CEO choice as friendly to potential takeover
Dec 21 The surprise selection of Michel Vounatsos to run Biogen Inc signals a shift toward a more commercial management focus after years of targeting ambitious scientific gains, and likely keeps the U.S. biotech in play as a takeover target. Vounatsos joined Biogen as chief commercial officer in April after 20 years leading various commercial operations at Merck & Co.

from Biotech News

First large-scale clinical study of long-acting injectable HIV drug begins

First large-scale clinical study of long-acting injectable HIV drug begins
The first large-scale clinical trial of a long-acting injectable drug for HIV prevention began today. The study, sponsored by the National Institutes of Health, will examine whether a long-acting form of the investigational anti-HIV drug cabotegravir injected once every 8 weeks can safely protect men and transgender women from HIV infection at least as well as the anti-HIV medication Truvada taken daily as an oral tablet.

from Biotech News

Pharma Swamp-Dwellers: Bribing Doctors to Poison Patients

Pharma Swamp-Dwellers: Bribing Doctors to Poison Patients
Big Pharma continues to find new ways to make itself the most hated industry in America, with a recent scandal now shedding light on just how far the industry is willing to go to pimp its product. That scandal is the recent arrest of Insys Therapeutics former CEO Michael Babich on grounds that would make even some hardened criminals' skin crawl.

from Biotech News

Value Fund L. P. Biotechnology Purchases 654,921 Shares of Infinity Pharmaceuticals Inc. (INFI) Stock

Value Fund L. P. Biotechnology Purchases 654,921 Shares of Infinity Pharmaceuticals Inc. (INFI) Stock
Infinity Pharmaceuticals Inc. major shareholder Value Fund L. P. Biotechnology acquired 654,921 shares of the firm's stock in a transaction that occurred on Tuesday, December 20th. The stock was bought at an average cost of $1.31 per share, with a total value of $857,946.51.

from Biotech News

MediciNova Announces European Commission Grants Orphan Medicinal...

MediciNova Announces European Commission Grants Orphan Medicinal...
MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market and the JASDAQ Market of the Tokyo Stock Exchange , today announced that the European Commission has granted Orphan Medicinal Product Designation for MN-166 for the treatment of amyotrophic lateral sclerosis . OMPD offers potential benefits including protocol assistance, fee reductions, and 10-year market exclusivity once the medicine is on the market in Europe.

from Biotech News

Bundeskartellamt genehmigt Fusion im Pharmagroßhandel

Bundeskartellamt genehmigt Fusion im Pharmagroßhandel
(dpa) Die Essener Apothekergenossenschaft Noweda darf den Pharmagroßhändler Ebert+Jacobi aus Würzburg Übernehmen. Das Bundeskartellamt gab am Dienstag den Zusammenschluss frei. Durch die Fusion rückt der Verbund im Pharmagroßhandel bundesweit hinter Phoenix auf die zweite Position vor, gefolgt von d...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.

Novartis vereinbart Zusammenarbeit mit Conatus

Novartis vereinbart Zusammenarbeit mit Conatus
(dpa-AFX) Novartis will mit Conatus Pharmaceuticals bei der Entwicklung eines oral einzunehmenden Medikaments zur Behandlung von nicht-alkoholischer Steatohepatitis (NASH) zusammenarbeiten. Eine entsprechende Option, Zusammenarbeit und Lizenzvereinbarungen seien zwischen den Unternehmen vereinbart w...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.

Sanofi talks with Actelion progressing - source

Sanofi talks with Actelion progressing - source
Dec 20 Talks between Actelion and Sanofi are making progress, despite investors' anxiety as to whether the Swiss biotech firm's chief executive really wants a deal, a person with direct knowledge of situation said on Tuesday. The source said Actelion had now reached a point where the company needed to sign a deal and it could not call off negotiations with the French drugmaker without triggering an investor rebellion demanding the overthrow of its board.

from Biotech News

PowerPoint: Blitzschnell ein Haken-Symbol in die Präsentation einfügen

PowerPoint: Blitzschnell ein Haken-Symbol in die Präsentation einfügen
Bei der Erstellung von bestimmten PowerPoint-Präsentationen können auch Symbole sehr hilfreich sein, zum Beispiel bei Listen oder bei Aufzählungen. Mit dem richtigen Kniff sparst du dir eine zeitraubende Suche über die Charmap (Zeichentabelle).Positioniere in deiner Präsentationsfolie den Cursor an der gewünschten Stelle und tippe dort den Buchstaben ü ein. Anschließend markierst du das ü und stellst als Schriftart Wingdings ein, die den Buchstaben in das Häkchen-Symbol umwandelt.Erscheint ein anderes Symbol als das Häkchen, dann überprüfe die Feststelltaste und deaktiviere sie gegebenenfalls.Eine weitere Möglichkeit, das Häkchen-Symbol in PowerPoint einzufügen, ist eine Tastenkombination. Als erstes stellst du auch hier die Schriftart auf Wingdings ein, drückst und hältst die Taste [Alt] und tippst dann über den Zahlenblock den Code 0252 ein.Eine dritte Variante führt über das Bearbeitungs-Band von PowerPoint. Wech…

Bristol-Myers Commits Up to $1B for Virus "Armed" to Fight Tumors

Bristol-Myers Commits Up to $1B for Virus "Armed" to Fight Tumors
Terms of the deal include an upfront payment of $50 million plus up to $886 million in development, regulatory and sales-based milestones. Bristol-Myers Squibb said Tuesday it has signed a deal worth up to $936 million plus royalties to secure worldwide rights to an "armed" oncolytic virus being developed by PsiOxus Therapeutics Ltd. to treat tumors.

from Biotech News

Bioinformatics brings to light new combinations of drugs to fight breast cancer

Bioinformatics brings to light new combinations of drugs to fight breast cancer
Combined therapy using two drugs emerges as a promising approach to tackle cancer resistance. Biocomputational analyses at IRB help to detect new synergistic combinations, such as raloxifene and cabozantinib, for the treatment of breast cancer.

from Biotech News

Harvard Bioscience an 'Asymmetrical Long Shot'

Harvard Bioscience an 'Asymmetrical Long Shot'
One of the best parts of writing for Real Money is all the great people I get to meet. I have made some great friends with fellow contributors and Real Money subscribers over the years, and I enjoy hearing from everyone who writes and comments on my articles.

from Biotech News

Progenics Pharmaceuticals Inc. (PGNX) Given a $11.00 Price Target by...

Progenics Pharmaceuticals Inc. (PGNX) Given a $11.00 Price Target by...
The brokerage presently has a "buy" rating on the stock. Needham & Company LLC's price target points to a potential upside of 23.04% from the stock's current price.

from Biotech News

Press release distribution, EDGAR filing, XBRL, regulatory filings

Press release distribution, EDGAR filing, XBRL, regulatory filings
When: Fr... IMPORTANT INVESTOR ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Illumina, Inc. and Encourages Investors with Losses to Contact the Firm )--Khang & Khang LLP announces the filing of a class action lawsuit against Illumina, Inc. .

from Biotech News

Finanzen: Stromvergleich : Stromvergleich

Nutzen Sie unseren verbraucherfreundlichen Tarifrechner, um ganz einfach zu einem günstigen und fairen Stromanbieter zu wechseln.

from Finanztip Feed
Supported by Video Collection

Finanzen: Stromanbieter wechseln : Stromanbieter wechseln

Etliche Haushalte in Deutschland zahlen deutlich zu viel für ihren Strom. Dabei ist ein günstiger Anbieter schnell gefunden – und der Wechsel ganz einfach.

from Finanztip Feed
Supported by Video Collection

Most actively traded companies on the TSX

Most actively traded companies on the TSX
Bombardier Inc. . Aerospace, rail equipment. Up 14 cents, or 6.83 per cent, to $2.19 on 13.1 million shares.

from Biotech News